About the Authors
- Aiko Kageyama
-
Affiliation Development Research, Mochida Pharmaceutical Co., Ltd., Gotemba, Shizuoka, Japan
- Hiroki Matsui
-
Affiliations Department of Medicine and Biological Science, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan, Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, Maebashi, Gunma, Japan
- Masahiko Ohta
-
Affiliation Development Research, Mochida Pharmaceutical Co., Ltd., Gotemba, Shizuoka, Japan
- Keisuke Sambuichi
-
Affiliation Development Research, Mochida Pharmaceutical Co., Ltd., Gotemba, Shizuoka, Japan
- Hiroyuki Kawano
-
* E-mail: h-kawano@mochida.co.jp
Affiliation Development Research, Mochida Pharmaceutical Co., Ltd., Gotemba, Shizuoka, Japan
- Tatsuto Notsu
-
Affiliation Development Research, Mochida Pharmaceutical Co., Ltd., Gotemba, Shizuoka, Japan
- Kazunori Imada
-
Affiliation Development Research, Mochida Pharmaceutical Co., Ltd., Gotemba, Shizuoka, Japan
- Tomoyuki Yokoyama
-
Affiliation Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, Maebashi, Gunma, Japan
- Masahiko Kurabayashi
-
Affiliation Department of Medicine and Biological Science, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan
Competing Interests
AK, MO, KS, HK, TN and KI are employees of Mochida pharmaceutical Co., LTD., whose company funded this study and sells EPA preparation. There are no further patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: AK HM MO HK MK. Performed the experiments: AK HM MO KS. Analyzed the data: AK HM MO HK TN KI TY MK. Wrote the paper: AK HM HK MK.